183 related articles for article (PubMed ID: 36343611)
1. An off-the-shelf multi-well scaffold-supported platform for tumour organoid-based tissues.
Li NT; Wu NC; Cao R; Cadavid JL; Latour S; Lu X; Zhu Y; Mijalkovic M; Roozitalab R; Landon-Brace N; Notta F; McGuigan AP
Biomaterials; 2022 Dec; 291():121883. PubMed ID: 36343611
[TBL] [Abstract][Full Text] [Related]
2. An Automation Workflow for High-Throughput Manufacturing and Analysis of Scaffold-Supported 3D Tissue Arrays.
Cao R; Li NT; Latour S; Cadavid JL; Tan CM; Forman A; Jackson HW; McGuigan AP
Adv Healthc Mater; 2023 Jul; 12(19):e2202422. PubMed ID: 37086259
[TBL] [Abstract][Full Text] [Related]
3. Testing Susceptibility of Patient-Derived Organoid Cultures to Therapies: Pharmacotyping.
Burkhart RA; Baker LA; Tiriac H
Methods Mol Biol; 2018; 1787():253-261. PubMed ID: 29736724
[TBL] [Abstract][Full Text] [Related]
4. Generation and Culture of Human Pancreatic Ductal Adenocarcinoma Organoids from Resected Tumor Specimens.
Baker LA; Tiriac H; Tuveson DA
Methods Mol Biol; 2019; 1882():97-115. PubMed ID: 30378047
[TBL] [Abstract][Full Text] [Related]
5. Modelling of pancreatic cancer biology: transcriptomic signature for 3D PDX-derived organoids and primary cell line organoid development.
Nelson SR; Zhang C; Roche S; O'Neill F; Swan N; Luo Y; Larkin A; Crown J; Walsh N
Sci Rep; 2020 Feb; 10(1):2778. PubMed ID: 32066753
[TBL] [Abstract][Full Text] [Related]
6. Isolation and Characterization of Patient-derived Pancreatic Ductal Adenocarcinoma Organoid Models.
Tiriac H; French R; Lowy AM
J Vis Exp; 2020 Jan; (155):. PubMed ID: 32009658
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic cancer-derived organoids - a disease modeling tool to predict drug response.
Frappart PO; Walter K; Gout J; Beutel AK; Morawe M; Arnold F; Breunig M; Barth TF; Marienfeld R; Schulte L; Ettrich T; Hackert T; Svinarenko M; Rösler R; Wiese S; Wiese H; Perkhofer L; Müller M; Lechel A; Sainz B; Hermann PC; Seufferlein T; Kleger A
United European Gastroenterol J; 2020 Jun; 8(5):594-606. PubMed ID: 32213029
[TBL] [Abstract][Full Text] [Related]
8. Generation and Culture of Tumor and Metastatic Organoids from Murine Models of Pancreatic Ductal Adenocarcinoma.
Baker LA; Tuveson DA
Methods Mol Biol; 2019; 1882():117-133. PubMed ID: 30378048
[TBL] [Abstract][Full Text] [Related]
9. Magnetic Fluid Hyperthermia as Treatment Option for Pancreatic Cancer Cells and Pancreatic Cancer Organoids.
Palzer J; Mues B; Goerg R; Aberle M; Rensen SS; Olde Damink SWM; Vaes RDW; Cramer T; Schmitz-Rode T; Neumann UP; Slabu I; Roeth AA
Int J Nanomedicine; 2021; 16():2965-2981. PubMed ID: 33935496
[TBL] [Abstract][Full Text] [Related]
10. Cancer-initiating cells in human pancreatic cancer organoids are maintained by interactions with endothelial cells.
Choi JI; Jang SI; Hong J; Kim CH; Kwon SS; Park JS; Lim JB
Cancer Lett; 2021 Feb; 498():42-53. PubMed ID: 33188841
[TBL] [Abstract][Full Text] [Related]
11. A T Cell-Engaging Tumor Organoid Platform for Pancreatic Cancer Immunotherapy.
Zhou Z; Van der Jeught K; Li Y; Sharma S; Yu T; Moulana I; Liu S; Wan J; Territo PR; Opyrchal M; Zhang X; Wan G; Lu X
Adv Sci (Weinh); 2023 Aug; 10(23):e2300548. PubMed ID: 37271874
[TBL] [Abstract][Full Text] [Related]
12. OrBITS: label-free and time-lapse monitoring of patient derived organoids for advanced drug screening.
Deben C; De La Hoz EC; Compte ML; Van Schil P; Hendriks JMH; Lauwers P; Yogeswaran SK; Lardon F; Pauwels P; Van Laere S; Bogaerts A; Smits E; Vanlanduit S; Lin A
Cell Oncol (Dordr); 2023 Apr; 46(2):299-314. PubMed ID: 36508089
[TBL] [Abstract][Full Text] [Related]
13. Patient-Derived Organoid Pharmacotyping Guides Precision Medicine for Pancreatic Cancer.
Zhang Y; Houchen CW; Li M
Clin Cancer Res; 2022 Aug; 28(15):3176-3178. PubMed ID: 35617521
[TBL] [Abstract][Full Text] [Related]
14. Single-cell transcriptome profiling of primary tumors and paired organoids of pancreatobiliary cancer.
Chen K; Ma Y; Zhong X; Lan J; Long D; Tian X; Yang Y; Yang Y
Cancer Lett; 2024 Feb; 582():216586. PubMed ID: 38081505
[TBL] [Abstract][Full Text] [Related]
15. Development of primary human pancreatic cancer organoids, matched stromal and immune cells and 3D tumor microenvironment models.
Tsai S; McOlash L; Palen K; Johnson B; Duris C; Yang Q; Dwinell MB; Hunt B; Evans DB; Gershan J; James MA
BMC Cancer; 2018 Mar; 18(1):335. PubMed ID: 29587663
[TBL] [Abstract][Full Text] [Related]
16. Advanced Development of Primary Pancreatic Organoid Tumor Models for High-Throughput Phenotypic Drug Screening.
Hou S; Tiriac H; Sridharan BP; Scampavia L; Madoux F; Seldin J; Souza GR; Watson D; Tuveson D; Spicer TP
SLAS Discov; 2018 Jul; 23(6):574-584. PubMed ID: 29673279
[TBL] [Abstract][Full Text] [Related]
17. Correlation between drug sensitivity profiles of circulating tumour cell-derived organoids and clinical treatment response in patients with pancreatic ductal adenocarcinoma.
Wu YH; Hung YP; Chiu NC; Lee RC; Li CP; Chao Y; Shyr YM; Wang SE; Chen SC; Lin SH; Chen YH; Kang YM; Hsu SM; Yen SH; Wu JY; Lee KD; Tseng HE; Tsai JR; Tang JH; Chiou JF; Burnouf T; Chen YJ; Wang PY; Lu LS
Eur J Cancer; 2022 May; 166():208-218. PubMed ID: 35306319
[TBL] [Abstract][Full Text] [Related]
18. Organoid models of human and mouse ductal pancreatic cancer.
Boj SF; Hwang CI; Baker LA; Chio II; Engle DD; Corbo V; Jager M; Ponz-Sarvise M; Tiriac H; Spector MS; Gracanin A; Oni T; Yu KH; van Boxtel R; Huch M; Rivera KD; Wilson JP; Feigin ME; Öhlund D; Handly-Santana A; Ardito-Abraham CM; Ludwig M; Elyada E; Alagesan B; Biffi G; Yordanov GN; Delcuze B; Creighton B; Wright K; Park Y; Morsink FH; Molenaar IQ; Borel Rinkes IH; Cuppen E; Hao Y; Jin Y; Nijman IJ; Iacobuzio-Donahue C; Leach SD; Pappin DJ; Hammell M; Klimstra DS; Basturk O; Hruban RH; Offerhaus GJ; Vries RG; Clevers H; Tuveson DA
Cell; 2015 Jan; 160(1-2):324-38. PubMed ID: 25557080
[TBL] [Abstract][Full Text] [Related]
19. Shared extracellular vesicle miRNA profiles of matched ductal pancreatic adenocarcinoma organoids and blood plasma samples show the power of organoid technology.
Zeöld A; Sándor GO; Kiss A; Soós AÁ; Tölgyes T; Bursics A; Szűcs Á; Harsányi L; Kittel Á; Gézsi A; Buzás EI; Wiener Z
Cell Mol Life Sci; 2021 Mar; 78(6):3005-3020. PubMed ID: 33237353
[TBL] [Abstract][Full Text] [Related]
20. Development of a miniaturized 3D organoid culture platform for ultra-high-throughput screening.
Du Y; Li X; Niu Q; Mo X; Qui M; Ma T; Kuo CJ; Fu H
J Mol Cell Biol; 2020 Aug; 12(8):630-643. PubMed ID: 32678871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]